As immune checkpoint inhibitors begin to reshape how to treat patients with cancer, understanding treatment-free survival as an endpoint in clinical research can better characterize the effects of the treatment.
Meredith M. Regan, ScD
Advertisement
Articles by Meredith M. Regan, ScD
Advertisement
Latest Updated Articles
Utilizing Treatment Free Survival as an Endpoint in ResearchPublished: November 28th 2019 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
VCN-01 Plus SOC Improves Survival, Is Safe in Metastatic PDAC
2
Older, Male Patients More Likely to Have CIP, Prospective Study Reveals
3
Buparlisib/Chemo Combo Misses OS Mark in PD-1–Treated Recurrent HNC
4
Ivonescimab Plus Chemo Extends PFS in Advanced Squamous NSCLC
5
